摘要:A field trial of dried BCG vaccine prepared with sodium glutamate as adjuvant was carried out by the WHO/UNICEF Tuberculosis Survey Team for West Africa in Ilorin, Nigeria, in April 1956. This trial—the first of a series of studies being undertaken jointly by the WHO Tuberculosis Research Office and the Japan Anti-Tuberculosis Association—was designed to test the heat-stability of the new dried vaccine. The allergenic potency six months after vaccination of two different lots of glutamate vaccine stored under various temperature conditions was compared with that of a batch of fresh liquid vaccine stored at 2-4° C. The results showed both lots of dried vaccine to be remarkably heat-stable: even after 30 days' exposure to tropical temperatures, no marked loss of allergenic potency was observed. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (419K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References . 289 290 291 292 293